The stock's fall snapped a two-day winning streak.
China’s drug regulator approved Merck & Co.’s blockbuster HPV vaccine for use by men, opening a new untapped market for the ...
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
U.S. drugmaker Merck & Co said on Wednesday its human papillomavirus (HPV) vaccine for men has been approved by China's ...
WuXi Biologics’ move to sell the facility could strengthen the company’s cash flow and margins as it navigates global ...
This was the stock's second consecutive day of gains.
Doctors may change how they treat liver cancer after drugs from AstraZeneca Plc and Merck & Co. helped some patients, marking ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Two late-stage studies published Wednesday in The Lancet show that Astra's Imfinzi and Merck's Keytruda delayed the progress ...
24/7 Wall St. on MSN22h
Merck Just Paid Investors: How Much Did They Receive?Merck just rewarded its shareholders again with a dividend hike. This Dow stock has come with a quarterly dividend for almost ...
Merck & Co Inc (MRK) stock saw a modest uptick, ending the day at $101.02 which represents a slight increase of $1.30 or 1.30% from the prior close of $99.72. The stock opened at $100.13 and touched a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback